| [3] |
De Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population[J]. PLoS One, 2013, 8 (5): 1224-1230.
|
| [4] |
Marsh S E, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes[J]. Thorax, 2008, 63(9): 761-767.
|
| [1] |
O’Donnell D E, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease 2007 update[J]. Can Respir J, 2007, 14(Suppl B): 5B-32B.
|
| [5] |
Gibson P G, simpson J L. The overlap syndrome of asthma and COPD: what are its features and how important is it?[J] .Thorax, 2009, 64(8):728-735.
|
| [2] |
JB S, KJ D, Coleman B, et al. The proportional Venn diagram of obstructive lung disease[J]. Chest, 2003, 124 (2): 474-481.
|
| [6] |
Rhee C K, Yoon H K, Yoo K H, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma[J]. COPD,2014,11(2): 163-170.
|
| [7] |
Menezes A M, Montes de Oca M, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma[J]. Chest, 2014, 145(2): 297-304.
|
| [3] |
De Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population[J]. PLoS One, 2013, 8 (5): 1224-1230.
|
| [8] |
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease NHLBI/WHO Workshop Report. Updated 2011.
|
| [4] |
Marsh S E, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes[J]. Thorax, 2008, 63(9): 761-767.
|
| [9] |
Douwes J, Gibson P, Pekkanen J, et al. Noneosinophilic asthma: importance and possible mechanisms[J]. Thorax, 2002, 57(7): 643-648.
|
| [5] |
Gibson P G, simpson J L. The overlap syndrome of asthma and COPD: what are its features and how important is it?[J] .Thorax, 2009, 64(8):728-735.
|
| [6] |
Rhee C K, Yoon H K, Yoo K H, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma[J]. COPD,2014,11(2): 163-170.
|
| [10] |
Kitaguchi Y, Komatsu Y, Fujimoto K, et al. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma[J]. Int J Chron Obstruct Pulmon Dis, 2012, 7(1):283-289.
|
| [7] |
Menezes A M, Montes de Oca M, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma[J]. Chest, 2014, 145(2): 297-304.
|
| [8] |
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease NHLBI/WHO Workshop Report. Updated 2011.
|
| [11] |
Bumbacea D, Campbell D, Nguyen L, et al. Parameters associated with persistent airflow obstruction in chronic severe asthma[J]. Eur Respir J, 2004, 24(1): 122-128.
|
| [9] |
Douwes J, Gibson P, Pekkanen J, et al. Noneosinophilic asthma: importance and possible mechanisms[J]. Thorax, 2002, 57(7): 643-648.
|
| [12] |
Skld C M. Remodeling in asthma and COPD-differences and similarities[J]. Clin Respir J, 2010, 4(Suppl 1): 20-27.
|
| [13] |
Vonk J M, Jongepier H, Panhuysen C I M, et al.Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up[J]. Thorax, 2003, 58(4): 322-327.
|
| [10] |
Kitaguchi Y, Komatsu Y, Fujimoto K, et al. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma[J]. Int J Chron Obstruct Pulmon Dis, 2012, 7(1):283-289.
|
| [11] |
Bumbacea D, Campbell D, Nguyen L, et al. Parameters associated with persistent airflow obstruction in chronic severe asthma[J]. Eur Respir J, 2004, 24(1): 122-128.
|
| [14] |
Papaiwannou A, Zarogoulidis P, Porpodis K, et al.Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review[J].Thorac Dis,2014,6(Suppl 1):S146-151.
|
| [12] |
Skld C M. Remodeling in asthma and COPD-differences and similarities[J]. Clin Respir J, 2010, 4(Suppl 1): 20-27.
|
| [13] |
Vonk J M, Jongepier H, Panhuysen C I M, et al.Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up[J]. Thorax, 2003, 58(4): 322-327.
|
| [15] |
Hardin M, Silverman E K, Barr R G, et al.The clinical features of the overlap between COPD and asthma[J]. Respir Res, 20ll, 12(27):127-128.
|
| [14] |
Papaiwannou A, Zarogoulidis P, Porpodis K, et al.Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review[J].Thorac Dis,2014,6(Suppl 1):S146-151.
|
| [16] |
Andersén H, Lampela P, Nevanlinna A, et al. High hospital burden in overlap syndrome of asthma and COPD[J]. Clin Respir J,2013, 7(4): 342-346.
|
| [17] |
Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life[J]. J Asthma, 2011, 48(3): 279-285.
|
| [18] |
Miravitlles M, Soriano J B, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status[J]. Respire Med, 2013, 107(7):1053-1060.
|
| [15] |
Hardin M, Silverman E K, Barr R G, et al.The clinical features of the overlap between COPD and asthma[J]. Respir Res, 20ll, 12(27):127-128.
|
| [19] |
Soler-Catalufia J J, Cosio B,Izquierdo J L, et al. Consensus document on the overlap phenotype COPD asthma in COPD[J]. Arch Bronconeumol, 2012, 48(9): 331-337.
|
| [16] |
Andersén H, Lampela P, Nevanlinna A, et al. High hospital burden in overlap syndrome of asthma and COPD[J]. Clin Respir J,2013, 7(4): 342-346.
|
| [17] |
Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life[J]. J Asthma, 2011, 48(3): 279-285.
|
| [20] |
Zeki A A, Schivo M, Chan A, et al. The asthma-COPD overlap syndrome: a common clinical problem in the elderly[J]. J Allergy, 2011:861926.
|
| [18] |
Miravitlles M, Soriano J B, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status[J]. Respire Med, 2013, 107(7):1053-1060.
|
| [21] |
Louie S, Zeki A A, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations[J]. Expert Rev Clin Pharmacol, 2013, 6(2):197-219.
|
| [19] |
Soler-Catalufia J J, Cosio B,Izquierdo J L, et al. Consensus document on the overlap phenotype COPD asthma in COPD[J]. Arch Bronconeumol, 2012, 48(9): 331-337.
|
| [22] |
Iwamoto H, Gao J, Koskela J. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap[J]. Eur Respir J, 2014, 43(2): 421-429.
|
| [20] |
Zeki A A, Schivo M, Chan A, et al. The asthma-COPD overlap syndrome: a common clinical problem in the elderly[J]. J Allergy, 2011:861926.
|
| [23] |
Hardin M, Cho M, McDonald M L, et al.The clinical and genetic features of COPD-asthma overlap syndrome[J]. Eur Respir J, 2014,(44): 341-350.
|
| [21] |
Louie S, Zeki A A, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations[J]. Expert Rev Clin Pharmacol, 2013, 6(2):197-219.
|
| [24] |
Miravitlles M, Soler-Catalua J J, Calle M, et al. Spanish COPD Guidelines(GesEPOC):pharmacological treatment of stable COPD[J]. Aten Primaria, 2012, 44(2): 425-437.
|
| [22] |
Iwamoto H, Gao J, Koskela J. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap[J]. Eur Respir J, 2014, 43(2): 421-429.
|
| [25] |
Siva R, Green R H, Brightling C E, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial[J]. Eur Respir J, 2007, 29(5): 906-913.
|
| [23] |
Hardin M, Cho M, McDonald M L, et al.The clinical and genetic features of COPD-asthma overlap syndrome[J]. Eur Respir J, 2014,(44): 341-350.
|
| [26] |
McDonald V, Higgins I, Wood L, et al. Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?[J]. Thorax, 2013, 68(7): 691-694.
|
| [27] |
Magnussen H, Bugnas B, van Noord J, et al. Improvements with tiotropium in COPD patients with concomitant asthma[J]. Respir Med, 2008, 102(1): 50-56.
|
| [24] |
Miravitlles M, Soler-Catalua J J, Calle M, et al. Spanish COPD Guidelines(GesEPOC):pharmacological treatment of stable COPD[J]. Aten Primaria, 2012, 44(2): 425-437.
|
| [28] |
Ohar J A, Donhue J F. Mono-and combination therapy of long acting brochodilators and inhaled corticosteroid in advanced COPD[J]. Semin Respir Crit Care Med, 2010, 31(3):321-333.
|
| [25] |
Siva R, Green R H, Brightling C E, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial[J]. Eur Respir J, 2007, 29(5): 906-913.
|
| [29] |
Bjerg A, Lundback B, Lotvall J. The future of combining inhaled drugs for COPD[J]. Curr Opin Pharmacol,2012,12(3):252-255.
|
| [26] |
McDonald V, Higgins I, Wood L, et al. Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?[J]. Thorax, 2013, 68(7): 691-694.
|
| [27] |
Magnussen H, Bugnas B, van Noord J, et al. Improvements with tiotropium in COPD patients with concomitant asthma[J]. Respir Med, 2008, 102(1): 50-56.
|
| [28] |
Ohar J A, Donhue J F. Mono-and combination therapy of long acting brochodilators and inhaled corticosteroid in advanced COPD[J]. Semin Respir Crit Care Med, 2010, 31(3):321-333.
|
| [29] |
Bjerg A, Lundback B, Lotvall J. The future of combining inhaled drugs for COPD[J]. Curr Opin Pharmacol,2012,12(3):252-255.
|
| [1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(9): 802-803. |
|
|
|
2015, Vol. 26 
